It's important to get a prompt diagnosis for a movement disorder or delays in your child's development. And muscle shortening and muscle rigidity can worsen if not treated aggressively. However, as the child gets older, some symptoms might become more or less apparent. The brain disorder causing cerebral palsy doesn't change with time, so the symptoms usually don't worsen with age. Mental health conditions, such as emotional disorders and behavioral problems.Bladder and bowel problems, including constipation and urinary incontinence.Problems with vision and abnormal eye movements.Delayed growth, resulting in smaller size than would be expectedĭamage to the brain can contribute to other neurological problems, such as:.Delays in reaching motor skills milestones, such as sitting up or crawling.Excessive drooling or problems with swallowing. Difficulty with sucking, chewing or eating.Difficulty with fine motor skills, such as buttoning clothes or picking up utensils.Difficulty walking, such as walking on toes, a crouched gait, a scissors-like gait with knees crossing, a wide gait or an asymmetrical gait.Favoring one side of the body, such as only reaching with one hand or dragging a leg while crawling.Lack of balance and muscle coordination (ataxia).Stiff muscles with normal reflexes (rigidity).Variations in muscle tone, such as being either too stiff or too floppy.Stiff muscles and exaggerated reflexes (spasticity), the most common movement disorder.Generally, signs and symptoms include problems with movement and coordination, speech and eating, development, and other problems. Cerebral palsy can affect the whole body, or it might be limited primarily to one or two limbs, or one side of the body. Data will be shared after approval of a proposal with investigator approval and completion of a signed data sharing agreement.Signs and symptoms of cerebral palsy can vary greatly from person to person. Requests for access to the data will be considered by the National Perinatal Epidemiology Unit Data Sharing committee from the date of publication. De-identified participant data will be shared in accordance with the National Perinatal Epidemiology Unit Data Sharing policy and Nuffield Department of Population Health Data Sharing policy. Provenance and peer review Not commissioned externally peer reviewed.ĭata availability statement Data may be obtained from a third party and are not publicly available. Patient consent for publication Not required.Įthics approval The trial was approved by Tayside Committee on Medical Research Ethics (08/S0501/31). TC: contributed to the design of the data analysis, reviewed and revised the manuscript and approved the final manuscript as submitted.įunding This study was funded by Medical Research Council (UK) and managed by NIHR on behalf of the MRC-NIHR partnership. AB: coordinated and supervised the analysis of blood spot cards, critically reviewed the manuscript and approved the final manuscript as submitted. JW: contributed to the data analysis, reviewed and revised the manuscript and approved the final manuscript as submitted. AL: contributed to the study design, critically reviewed the manuscript and approved the final manuscript as submitted. Contributors FLRW: conceptualised and designed the study, designed and contributed to the data analysis, drafted the initial manuscript and approved the final manuscript as submitted.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |